Michel Detheux is Chief Executive Officer of iTeos Therapeutics, Inc. (ITOS). The company reported total compensation of $6,085,657 for fiscal year 2024.
| Salary | $628,684 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $4,965,264 |
| Non-equity incentive plan | $421,014 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $70,695 |
| Total | $6,085,657 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure iTeos Therapeutics, Inc. filed April 24, 2025, accession 0000950170-25-057666.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2024 | Chief Executive Officer | $628,684 | $0 | $0 | $4,965,264 | $421,014 | $0 | $70,695 | $6,085,657 |
| FY2023 | Chief Executive Officer | $578,863 | $0 | $295,200 | $4,428,800 | $384,516 | $0 | $80,395 | $5,767,774 |
Totals as disclosed in each year's own compensation disclosure for iTeos Therapeutics, Inc..
| Named executive officer | Role | FY2024 total |
|---|---|---|
| Michel Detheux this page | Chief Executive Officer | $6,085,657 |
| David Feltquate | Chief Medical Officer | $5,055,005 |
| Matthew Call | Chief Operating Officer | $2,617,730 |
The company's named executive officers for fiscal year 2024, and what it reported for each. See the full iTeos Therapeutics, Inc. compensation brief.
Michel Detheux's compensation sits inside iTeos Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.